CASEY NORTON: Open Payments
NPI 1437575065 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 10 payments from 6 companies in 2025. Trend: 2023 $390 · 2024 $326 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $51 |
| Exeltis, USA Inc. | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Hologic Sales and Service, LLC | 1 | $24 |
| CooperSurgical, Inc. | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $5 |
Products named: Veozah, SLYND, GEMTESA, NOVASURE, Paragard T 380A.
Industry payments across IN — which companies pay providers there.
